Incidence of injection-site blemishes in beef top sirloin butts

Roeber, D.L.; Cannell, R C; Belk, K. E.; Scanga, J. A.; Cowman, G L; Smith, G. C.

doi:10.2527/1994.724824x

Cited by 33 publications

(32 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Large proportions of these are intended for intramuscular injection and are often administered by farmers. Injections can cause trauma to tissues, resulting in an inflammatory response and potential injection-site lesions (ISLs) such as cysts, discolouration, nodules or abscesses and subsequent scar tissue (Dexter and others 1994, Van Donkersgoed and others 1999, Roeber and others 2001). …”

mentioning

confidence: 99%

Injection‐site lesion prevalence and potential risk factors in UK beef cattle

Cresswell¹,

Remnant

Butterworth

et al. 2017

Veterinary Record

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Injection‐site lesion prevalence and potential risk factors in UK beef cattle

Cresswell¹,

Remnant

Butterworth

et al. 2017

Veterinary Record

View full text Add to dashboard Cite

show abstract

“…First, an injection given in the muscle may or may not result in a lesion (Field and Taylor 2004). Second, Dexter et al (1994) found that a majority (on average 85%) of the blemishes in top sirloin butts originated at the cow-calf, stocker, or very early in the finishing stages. No data are available for other cuts so we assume it is the same for them.…”

Section: Parameter Identificationmentioning

confidence: 98%

A Principal‐Agent Model for Evaluating the Economic Value of a Traceability System: A Case Study with Injection‐site Lesion Control in Fed Cattle

Filho

Buhr

2008

American J Agri Economics

View full text Add to dashboard Cite

Traceability can link the identity of cattle feeders with retail beef cuts. The economic problem for the packer implementing traceability is to choose the level of investment in traceability and the level of incentive payments to cattle feeders so that cattle feeders will avoid production actions that can damage retail beef cuts. A case study of injection-site lesions in cattle is the basis for technical parameters to numerically solve this principal-agent problem. Results show that cattle feeders will give injections in sites preferred by the packer even with low rates of successful tracking and minimal incentives. Copyright 2008, Oxford University Press.

show abstract

“…Tissue damage resulting from the injection of veterinary drugs in food‐producing animals represents a quality control problem for the livestock industry (Dexter et al. , 1994; George et al.…”

Section: Issues That Set Injection Site Residues Apartmentioning

confidence: 99%

Residues of veterinary drugs at injection sites

Reeves

2007

Vet Pharm & Therapeutics

View full text Add to dashboard Cite

Residues of veterinary drugs have potential implications for human food safety and international trade in animal-derived food commodities. A particular concern is the slow depletion of residues of some injectable formulations from the site of administration. Licensing authorities have adopted different approaches to the human food safety assessment of injection site residues. European agencies apply the maximum residue limit (MRL) for muscle to muscle at the injection site and specify a withdrawal period sufficient to ensure the ingestion of a 300 g portion of muscle, if comprised entirely of injection site tissue, does not exceed the acceptable daily intake. The agencies in Australia, Canada and the USA also exclude injection site residues from the MRL-setting process. These agencies evaluate the risk to consumers posed by potential acute manifestations resulting from the infrequent ingestion of injection site residues based on acute dietary exposure considerations. While all of these approaches protect the safety of consumers, the adoption of different approaches has potential implications for residue surveillance programs in the international trade in meat. In particular, when an exporting country establishes standards for residues at injection sites based on acute dietary exposure considerations and the importing country assesses these residues against the MRL for muscle, the unnecessary condemnation of meat and disruption to market access may result. The latter may represent a potential economical impost to the exporting country. An internationally harmonized approach to the risk analysis of residues of veterinary drugs at injection sites, which protects the safety of consumers and facilitates the international trade in meat, is needed.

show abstract

Incidence of injection-site blemishes in beef top sirloin butts

Cited by 33 publications

References 1 publication

Injection‐site lesion prevalence and potential risk factors in UK beef cattle

Injection‐site lesion prevalence and potential risk factors in UK beef cattle

A Principal‐Agent Model for Evaluating the Economic Value of a Traceability System: A Case Study with Injection‐site Lesion Control in Fed Cattle

Residues of veterinary drugs at injection sites

Contact Info

Product

Resources

About